Home
About
Publications Trends
Recent Publications
Expert Search
Archive
neonatal conjunctivitis
What are the Causes?
The most common causes of neonatal conjunctivitis are infectious agents. These include bacteria, viruses, and sometimes fungi. The primary infectious agents are:
Chlamydia trachomatis
Neisseria gonorrhoeae
Herpes Simplex Virus
Staphylococcus aureus
Streptococcus pneumoniae
Haemophilus influenzae
Non-infectious causes can include chemical irritants such as silver nitrate, which was historically used in prophylaxis against gonococcal infection.
Frequently asked queries:
What is Neonatal Conjunctivitis?
What are the Causes?
What is Chronic Infection?
What Are Some Examples of Pathogen-Induced Epigenetic Changes?
How is a Biopsy Performed?
Can Monogamous Relationships Prevent Non-Sexual Infectious Diseases?
What Types of Infections Can PCR Detect?
How Do Surveillance Systems Work?
How are Pediatric Infectious Diseases Diagnosed?
What are the Clinical Implications of the Inflammatory Response?
How Does COVID-19 Spread?
What Are Vector-Borne Diseases and How Are They Affected?
What Research is Being Conducted on Apicoplasts?
How to manage and prevent drug interactions?
How Has HTS Contributed to Recent Advances in Infectious Diseases?
Are There Concerns About Antiviral Resistance?
What Are the Challenges in Implementing AI?
What is Lyme Disease?
How Does the FDA Collaborate Internationally?
How is Zika Virus Diagnosed?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Antimicrobial Resistance
Apicoplast
Emerging Infectious Diseases
Fungal Infection
Genetic immunity
infections
Infectious Diseases
Lyme Disease
Measle
Pathogenesis
Vector-Borne Diseases
Viral infections
Partnered Content Networks
Relevant Topics
AMR
Anopheles mosquitoes
Antimalarial therapy
antimicrobial resistance
antimicrobial stewardship
Apicoplast
Aspergillus
biomarker detection
biosynthesis
Borrelia burgdorferi
Candida auris
CAPA
cell wall
Chikungunya
climate change
climate change effects
Co-infection
community engagement
COVID-19
COVID-19 pandemic
dengue
Diagnosis
diagnostics
disease control
Disease Resistance
diseases
drug resistance
Drug target
Ebola outbreak
electrochemical biosensors
Emerging infectious diseases
environmental factors
Epidemiology
Epigenetics
Evolutionary biology
Fatty acid synthesis
Fungal infections
Galactomannan
Genetic immunity
Genetic polymorphism
global health
healthcare infrastructure
healthcare systems
HIV
Host-Parasite Interaction
human medicine
immune evasion
Immune response
immunization programs
infection control
infectious disease management
Infectious diseases
Influenza
Inherited immunity
international support
Isoprenoid biosynthesis
LAM
Lyme disease
Malaria
malaria resurgence
measles elimination
Metabolic pathways
MHC Genes
Molecular diagnostics
Mycobacterium tuberculosis
mycolic acids
nanotechnology
Neisseria gonorrhoeae
One Health
pathogenesis
pediatric infectious diseases
Personalized medicine
Plasmodium falciparum
point-of-care
preventive measures
Protein targeting
Public health
Respiratory viruses
SARS-CoV-2
Sensitivity
sexually transmitted infections
Specificity
surveillance systems
TB treatment.
tick ecology
tick habitats
tick-borne illness
tuberculosis
Vaccination
vaccination coverage
vaccine hesitancy
vector- borne diseases
veterinary medicine
Viral infections
Viral interference
West Africa
Zika
Zika virus
zoonotic diseases
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Infectious Diseases.
Subscribe